Top 5 Stocks Billionaire George Soros Just Bought

Immunomedics, Inc. (NASDAQ:IMMU) is another merger play that Soros Fund jumped at the chance to play during Q3, buying 384,096 shares during the quarter. That position was worth $32.66 million on September 30, ranking as the family office’s 25^th most valuable 13F holding at that time.

Gilead Sciences Inc (NASDAQ:GILD) announced that it would acquire Immunomedics for $21 billion in cash, paying more than double what IMMU’s market value was before the announcement, a huge score for IMMU shareholders like Kurt Von Emster’s VenBio Select Advisor, which had over 18% exposure to IMMU as of June 30. In Tao Value’s Q3 investor letter, the Gilead shareholder expected the deal to be significantly accretive to Gilead’s bottom-line by 2023.